OKYO
OKYO Pharma Ltd
1.40$
-1.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.01 | -0.01 | -0.21 | -0.31 | -1.09 | -0.86 | -0.75 | -0.23 | -0.11 | -0.11 | -0.27 | -0.25 | -0.13 | -0.15 | -0.36 | -0.35 | -0.32 | -0.05 | -0.16 | |
| – | – | – | – | 0.00 | 0.01 | 0.02 | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.04 | 0.00 | 0.04 | 0.04 | 0.19 | 0.30 | 0.30 | 0.03 | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 | 0.05 | 0.11 | 0.06 | 0.04 | 0.02 | 0.04 | |
| – | – | – | – | – | – | – | – | – | – | 3.23 | 0.27 | 0.01 | 0.09 | 0.05 | – | – | – | – | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | -0.10 | -0.01 | -0.01 | 0.02 | -0.07 | 0.01 | 0.02 | 0.02 | 0.10 | -0.07 | 0.18 | 0.09 | 0.04 | -0.02 | |
| 0.05 | 0.02 | 0.00 | 0.00 | 0.82 | 1.62 | 2.30 | 0.44 | 0.07 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.05 | -0.38 | 4.86 | 6.80 | -0.96 | -1.62 | -2.29 | -0.44 | -0.06 | -0.06 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | – | 0.00 | -0.16 | |
| – | – | – | 9.51 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.57 | 0.00 | 0.09 | 0.00 | 0.02 | 0.00 | |
| 0.38 | 0.13 | 0.24 | -9.38 | 2.16 | 1.96 | 2.25 | 0.06 | 0.00 | 0.00 | 0.13 | 0.10 | 0.11 | 0.76 | 0.14 | 0.42 | 0.21 | 0.07 | 0.67 | |
| 0.32 | -0.25 | 4.90 | -2.88 | 0.24 | -0.41 | -0.84 | -0.65 | -0.20 | -0.11 | -0.27 | -0.25 | -0.04 | 0.64 | -0.28 | 0.06 | -0.11 | 0.02 | 0.35 | |
| -0.06 | -0.03 | -0.21 | -0.31 | -1.91 | -2.48 | -3.05 | -0.67 | -0.18 | -0.18 | -0.27 | -0.25 | -0.13 | -0.16 | -0.36 | -0.35 | -0.32 | -0.05 | -0.16 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.